3-5
2026
影响因子区间
—
平台估算
47%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:The goal of the journal is to publish original research findings and critical reviews that contribute to our knowledge about the composition, properties, and performance of materials for all applications relevant to human healthcare.Typical areas of interest include (but are not limited to):-Synthesis/characterization of biomedical materials-Nature-inspired synthesis/biomineralization of biomedical materials-In vitro/in vivo performance of biomedical materials-Biofabrication technologies/applications: 3D bioprinting, bioink development, bioassembly & biopatterning-Microfluidic systems (including disease models): fabrication, testing & translational applications-Tissue engineering/regenerative medicine-Interaction of molecules/cells with materials-Effects of biomaterials on stem cell behaviour-Growth factors/genes/cells incorporated into biomedical materials-Biophysical cues/biocompatibility pathways in biomedical materials performance-Clinical applications of biomedical materials for cell therapies in disease (cancer etc)-Nanomedicine, nanotoxicology and nanopathology-Pharmacokinetic considerations in drug delivery systems-Risks of contrast media in imaging systems-Biosafety aspects of gene delivery agents-Preclinical and clinical performance of implantable biomedical materials-Translational and regulatory matters
【译文】该期刊的目标是发表原创研究论文和批判性评论,以丰富我们对与人类医疗保健相关的所有应用中材料组成、性质和性能的知识。典型的研究领域包括但不限于:-生物医学材料的合成/表征-受自然界启发的生物医学材料的合成/生物矿化-生物医学材料在体外/体内的性能-生物制造技术/应用:3D生物打印、生物墨水开发、生物组装与生物图案化-微流控系统(包括疾病模型):制造、测试与应用转化-组织工程/再生医学-分子/细胞与材料的相互作用-生物材料对干细胞行为的影响-生物医学材料中的生长因子/基因/细胞-生物医学材料性能中的生物物理线索/生物相容性途径-生物医学材料在疾病(癌症等)细胞治疗中的临床应用-纳米医学、纳米毒理学和纳米病理学-药物输送系统中的药代动力学考虑-成像系统中对比剂的危害-基因递送剂的生物安全方面-植入式生物医学材料的临床前和临床性能-转化和监管问题

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |